Selected research
Industry Research
Asthma Reliever (Rescue) Medications Industry Research Report 2026
Market perspective
The global Asthma Reliever (Rescue) Medications market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Asthma Reliever (Rescue) Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Asthma Reliever (Rescue) Medications is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Asthma Reliever (Rescue) Medications is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Asthma Reliever (Rescue) Medications include AstraZeneca plc, Dulera, Genentech Inc, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, QVAR, Roche Holdings Ltd and Sanofi-Aventis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Asthma Reliever (Rescue) Medications market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Asthma Reliever (Rescue) Medications Market by Company
AstraZeneca plc
Dulera
Genentech Inc
Glaxosmithkline plc
MAP Pharmaceuticals，Inc
Merck & Co. Inc
QVAR
Roche Holdings Ltd
Sanofi-Aventis
Schering-Plough Corp
Sepracor, Inc
Theravance Inc
Asthma Reliever (Rescue) Medications Segment by Type
Quick-Relief Medications
Long-Term Control Medications
Asthma Reliever (Rescue) Medications Segment by Application
Adult
Children
Adolescent
Asthma Reliever (Rescue) Medications Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Reliever (Rescue) Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Asthma Reliever (Rescue) Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Reliever (Rescue) Medications.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Asthma Reliever (Rescue) Medications manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Asthma Reliever (Rescue) Medications by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Asthma Reliever (Rescue) Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Quick-Relief Medications
- Long-Term Control Medications
Applications
- Adult
- Children
- Adolescent
Companies covered
- AstraZeneca plc
- Dulera
- Genentech Inc
- Glaxosmithkline plc
- MAP Pharmaceuticals，Inc
- Merck & Co. Inc
- QVAR
- Roche Holdings Ltd
- Sanofi-Aventis
- Schering-Plough Corp
- Sepracor, Inc
- Theravance Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Asthma Reliever (Rescue) Medications Market Size (2021-2032)
- 2.2.2 Global Asthma Reliever (Rescue) Medications Sales (2021-2032)
- 2.2.3 Global Asthma Reliever (Rescue) Medications Market Average Price (2021-2032)
- 2.3 Asthma Reliever (Rescue) Medications by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Quick-Relief Medications
- 2.3.3 Long-Term Control Medications
- 2.4 Asthma Reliever (Rescue) Medications by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Children
- 2.4.4 Adolescent
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Asthma Reliever (Rescue) Medications Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Asthma Reliever (Rescue) Medications Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Asthma Reliever (Rescue) Medications Revenue of Manufacturers (2021-2026)
- 3.4 Global Asthma Reliever (Rescue) Medications Average Price by Manufacturers (2021-2026)
- 3.5 Global Asthma Reliever (Rescue) Medications Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Asthma Reliever (Rescue) Medications, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Asthma Reliever (Rescue) Medications, Product Type & Application
- 3.8 Global Manufacturers of Asthma Reliever (Rescue) Medications, Established Date
- 3.9 Global Asthma Reliever (Rescue) Medications Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AstraZeneca plc
- 4.1.1 AstraZeneca plc Company Information
- 4.1.2 AstraZeneca plc Business Overview
- 4.1.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio
- 4.1.5 AstraZeneca plc Recent Developments
- 4.2 Dulera
- 4.2.1 Dulera Company Information
- 4.2.2 Dulera Business Overview
- 4.2.3 Dulera Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dulera Asthma Reliever (Rescue) Medications Product Portfolio
- 4.2.5 Dulera Recent Developments
- 4.3 Genentech Inc
- 4.3.1 Genentech Inc Company Information
- 4.3.2 Genentech Inc Business Overview
- 4.3.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio
- 4.3.5 Genentech Inc Recent Developments
- 4.4 Glaxosmithkline plc
- 4.4.1 Glaxosmithkline plc Company Information
- 4.4.2 Glaxosmithkline plc Business Overview
- 4.4.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio
- 4.4.5 Glaxosmithkline plc Recent Developments
- 4.5 MAP Pharmaceuticals，Inc
- 4.5.1 MAP Pharmaceuticals，Inc Company Information
- 4.5.2 MAP Pharmaceuticals，Inc Business Overview
- 4.5.3 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product Portfolio
- 4.5.5 MAP Pharmaceuticals，Inc Recent Developments
- 4.6 Merck & Co. Inc
- 4.6.1 Merck & Co. Inc Company Information
- 4.6.2 Merck & Co. Inc Business Overview
- 4.6.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio
- 4.6.5 Merck & Co. Inc Recent Developments
- 4.7 QVAR
- 4.7.1 QVAR Company Information
- 4.7.2 QVAR Business Overview
- 4.7.3 QVAR Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 QVAR Asthma Reliever (Rescue) Medications Product Portfolio
- 4.7.5 QVAR Recent Developments
- 4.8 Roche Holdings Ltd
- 4.8.1 Roche Holdings Ltd Company Information
- 4.8.2 Roche Holdings Ltd Business Overview
- 4.8.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio
- 4.8.5 Roche Holdings Ltd Recent Developments
- 4.9 Sanofi-Aventis
- 4.9.1 Sanofi-Aventis Company Information
- 4.9.2 Sanofi-Aventis Business Overview
- 4.9.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio
- 4.9.5 Sanofi-Aventis Recent Developments
- 4.10 Schering-Plough Corp
- 4.10.1 Schering-Plough Corp Company Information
- 4.10.2 Schering-Plough Corp Business Overview
- 4.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio
- 4.10.5 Schering-Plough Corp Recent Developments
- 4.11 Sepracor, Inc
- 4.11.1 Sepracor, Inc Company Information
- 4.11.2 Sepracor, Inc Business Overview
- 4.11.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio
- 4.11.5 Sepracor, Inc Recent Developments
- 4.12 Theravance Inc
- 4.12.1 Theravance Inc Company Information
- 4.12.2 Theravance Inc Business Overview
- 4.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio
- 4.12.5 Theravance Inc Recent Developments
5 Global Asthma Reliever (Rescue) Medications Market Scenario by Region
- 5.1 Global Asthma Reliever (Rescue) Medications Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Asthma Reliever (Rescue) Medications Sales by Region: 2021-2032
- 5.2.1 Global Asthma Reliever (Rescue) Medications Sales by Region: 2021-2026
- 5.2.2 Global Asthma Reliever (Rescue) Medications Sales by Region: 2027-2032
- 5.3 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2021-2032
- 5.3.1 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2021-2026
- 5.3.2 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2027-2032
- 5.4 North America Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
- 5.4.1 North America Asthma Reliever (Rescue) Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
- 5.4.3 North America Asthma Reliever (Rescue) Medications Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
- 5.5.1 Europe Asthma Reliever (Rescue) Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
- 5.5.3 Europe Asthma Reliever (Rescue) Medications Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
- 5.6.1 Asia Pacific Asthma Reliever (Rescue) Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
- 5.7.1 South America Asthma Reliever (Rescue) Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
- 5.7.3 South America Asthma Reliever (Rescue) Medications Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Asthma Reliever (Rescue) Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2021-2032)
- 6.1.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2021-2032)
- 6.2 Global Asthma Reliever (Rescue) Medications Revenue by Type (2021-2032)
- 6.2.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2021-2032)
- 6.3 Global Asthma Reliever (Rescue) Medications Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2021-2032)
- 7.1.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2021-2032)
- 7.2 Global Asthma Reliever (Rescue) Medications Revenue by Application (2021-2032)
- 7.2.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2021-2032)
- 7.3 Global Asthma Reliever (Rescue) Medications Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Asthma Reliever (Rescue) Medications Value Chain Analysis
- 8.1.1 Asthma Reliever (Rescue) Medications Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Asthma Reliever (Rescue) Medications Production Mode & Process
- 8.2 Asthma Reliever (Rescue) Medications Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Asthma Reliever (Rescue) Medications Distributors
- 8.2.3 Asthma Reliever (Rescue) Medications Customers
9 Global Asthma Reliever (Rescue) Medications Analyzing Market Dynamics
- 9.1 Asthma Reliever (Rescue) Medications Industry Trends
- 9.2 Asthma Reliever (Rescue) Medications Industry Drivers
- 9.3 Asthma Reliever (Rescue) Medications Industry Opportunities and Challenges
- 9.4 Asthma Reliever (Rescue) Medications Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst